Increasing Clinical Virulence in Two Decades of the Italian HIV Epidemic
暂无分享,去创建一个
Carlo Torti | Andrea De Luca | V. Müller | A. Antinori | A. De Luca | C. Torti | G. Carosi | Andrea Antinori | E. Quiros-Roldan | Giampiero Carosi | F. Maggiolo | F. Suter | Laura Sighinolfi | Viktor Müller | Eugenia Quiros-Roldan | Franco Maggiolo | Fredy Suter | Nicoletta Ladisa | L. Sighinolfi | N. Ladisa
[1] Roel A. Coutinho,et al. Time from HIV-1 seroconversion to Aids and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis: collaborative Group on Aids incubation and HIV survival including the CASCADE EU concerted action , 2000 .
[2] A. Lapedes,et al. Timing the ancestor of the HIV-1 pandemic strains. , 2000, Science.
[3] R. Raiteri,et al. Is the clinical course of HIV-1 changing? Cohort study , 1997, BMJ.
[4] D. Pillay,et al. The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy , 2006, AIDS.
[5] R. Hogg,et al. Impact of Neighborhood-Level Socioeconomic Status on HIV Disease Progression in a Universal Health Care Setting , 2008, Journal of acquired immune deficiency syndromes.
[6] J. Phair,et al. Evaluation of secular trends in CD4+ lymphocyte loss among human immunodeficiency virus type 1 (HIV-1)-infected men with known dates of seroconversion. , 1995, American journal of epidemiology.
[7] J. S. Sullivan,et al. Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.
[8] Giovanni Rezza,et al. Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985–2002 , 2005, AIDS.
[9] J. Kaldor,et al. HIV infection in recipients of blood products from donors with known duration of infection , 1994, The Lancet.
[10] S. Lawn. AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection. , 2004, The Journal of infection.
[11] G. Rutherford,et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. , 1989, The New England journal of medicine.
[12] I. Thior,et al. Human immunodeficiency virus type 1 subtypes differ in disease progression. , 1999, The Journal of infectious diseases.
[13] Gayathri Athreya,et al. Unequal Evolutionary Rates in the Human Immunodeficiency Virus Type 1 (HIV-1) Pandemic: the Evolutionary Rate of HIV-1 Slows Down When the Epidemic Rate Increases , 2007, Journal of Virology.
[14] Sebastian Bonhoeffer,et al. Stable virulence levels in the HIV epidemic of Switzerland over two decades , 2006, AIDS.
[15] D. Vlahov,et al. Recent infection with human immunodeficiency virus and possible rapid loss of CD4 T lymphocytes. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[16] E. Domingo,et al. Molecular Basis for a Lack of Correlation between Viral Fitness and Cell Killing Capacity , 2007, PLoS pathogens.
[17] E. Arts,et al. Replicative fitness of historical and recent HIV-1 isolates suggests HIV-1 attenuation over time , 2005, AIDS.
[18] S. Roberts,et al. GB virus C: insights into co-infection. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[19] Jacques Fellay,et al. A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 , 2007, Science.
[20] P. Vanhems,et al. Association between the rate of CD4+ T cell decrease and the year of human immunodeficiency virus (HIV) type 1 seroconversion among persons enrolled in the Swiss HIV cohort study. , 1999, The Journal of infectious diseases.
[21] T. Déirdre Hollingsworth,et al. Variation in HIV-1 set-point viral load: Epidemiological analysis and an evolutionary hypothesis , 2007, Proceedings of the National Academy of Sciences.
[22] Scott Wegner,et al. Is HIV becoming more virulent? Initial CD4 cell counts among HIV seroconverters during the course of the HIV epidemic: 1985-2007. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] John W. Mellors,et al. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.
[24] A. Phillips,et al. Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. , 2007, The Journal of infectious diseases.
[25] G. Touloumi. Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion , 2003 .
[26] Hiv Survival,et al. Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis , 2000, The Lancet.
[27] J. Margolick,et al. Lack of Evidence for Changing Virulence of HIV-1 in North America , 2008, PloS one.
[28] E. Arts,et al. Is HIV-1 evolving to a less virulent form in humans? , 2007, Nature Reviews Microbiology.
[29] Michael J. Crawley,et al. The R book , 2022 .
[30] M. Prins,et al. Differences in CD4 Cell Counts at Seroconversion and Decline Among 5739 HIV-1–Infected Individuals with Well-Estimated Dates of Seroconversion , 2003, Journal of acquired immune deficiency syndromes.
[31] Ben Berkhout,et al. Survey of the temporal changes in HIV-1 replicative fitness in the Amsterdam Cohort. , 2007, Virology.
[32] I. Keet,et al. Temporal trends of the natural history of HIV-1 infection following seroconversion between 1984 and 1993. , 1996, AIDS.